China Professor Richard Barker, founder of New Medicine Partners reflects on China’s very different approach to the biopharma industry. Napoleon once said: “China is a sleeping giant. Let her sleep, for when she wakes she will shake the world.” Well, in biotech, she is now wide awake I’ve recently returned from…
regulation Chinese ecommerce behemoths Alibaba and JD.com are being used to buy and sell tens of thousands of prescription medicines, skirting regulations in what is a legal grey area. According to a recent Financial Times report, dozens of listings from third party vendors – mainly pharmacies – for drugs such as…
Hong Kong Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has a long tradition in Asia. What capabilities have you developed over the years in the region? Zuellig Pharma started operations…
Innovation Andy A. Liu, CEO of CW Data Technologies, a joint venture between WuXi AppTec and China Electronics Data Corporation at the intersection of Big Data and healthcare, discusses emerging trends in healthcare technology and Hong Kong’s potential as an innovation incubator. Andy, prior to your current role as CEO…
Hong Kong Wolfgang Niedermark of GIC in Hong Kong, part of the AHK network of German Chambers of Commerce worldwide assesses the business relationship between Germany and Asia and how Hong Kong compares to its regional competitors as an investment destination What is your assessment of the business relationship between Germany and…
Hong Kong Matthew Man, CEO of Hong Kong cold chain monitoring technology specialist Myndar, expounds on the company’s formation, its differentiating factors, and countering resistance to new innovations in the healthcare sector. How did you identify the niche in the market for your cold chain monitoring technologies? I founded Myndar back…
Hong Kong Dr. Sze-fai YIP, Chairman of the Hong Kong Society of Haematology (HKSH), shares the mission of the society to support healthcare professionals and other stakeholders within the area of haematology in order to drive better health outcomes, the challenges faced by haematology patients in Hong Kong, and the potential of…
Hong Kong Ian Huen, founder and CEO of Aptorum Group, discusses why Hong Kong was the ideal location to base the company, its exciting development pipeline and his unique management philosophy. Ian, with your asset management background, could you share what inspired you to establish Aptorum Group in 2016? My biotech journey…
Hong Kong Colman Chan, CEO of ophthalmology specialist Skyview Optical, outlines recent developments in the Hong Kong eyecare market, Skyview’s evolution as a distributor and how it can foster greater links with Mainland China. What have been some of Skyview Optical’s main achievements and milestones since its establishment? Since creating the company…
Hong Kong Professor Anne W.M. Lee, vice chairman of the Hong Kong Anti-Cancer Society, discusses the role of patient associations in driving change within healthcare systems. Professor Lee, could you perhaps start by sharing the current strategic priorities of the Hong Kong Anti-Cancer Society (HKACS)? As the biggest non-government organization (NGO) in…
Hong Kong Dr. Daniel Thurley, general manager of Roche Hong Kong and Macau, shares his first impressions of the affiliate, the strategic significance of Hong Kong to Roche globally, the innovative medicines and technology Roche is committed to bringing to Hong Kong, and his insights on Roche’s commitment to patient-centricity. There have…
China Simon Yam, managing director of Geodis Greater China, shares the importance of the Greater China region to Geodis globally, the region’s strong performance and growth, the strategic importance of the healthcare and life sciences sector to their business, and the value-added, niche services and solutions they are committed to offering…
See our Cookie Privacy Policy Here